Background: Anxiety disorder, the most common mental health issue, can cause palpitations, fear, and compulsive behavior, and can severely endanger human health. Most drugs to treat anxiety disorder can cause a variety of side effects, therefore, it is important to seek natural and safe complementary and alternative therapies.Methods: The open field (OF), elevated plus maze (EPM), and light-dark box (LDB) tests were used to confirm the anxiolytic effect of BEO in mice. Further, we constructed a component-target-signaling pathway network and a protein-protein interaction (PPI) network for the regulation of anxiety by BEO through pharmacological network analyses, and performed Gene Ontology (GO) enrichment analyses of BEO targets, and analyzed the active components and targets of BEO through molecular docking.Results: In the OF test, BEO significantly prolonged the time spent by the mice in the central area (p < 0.05), in a dose dependent manner (r = 0.9992), and also significantly increased the number of central area entries (p < 0.01). In the EPM test, BEO significantly increased the time spent in the open arms (p < 0.01) and the number of entries into the open arms (p < 0.01) in a dose-dependent manner (r = 0.9733, r = 0.9669). In the LDB tests, BEO significantly increased the light area duration (p < 0.05) and the transition number (p < 0.01) in a dose-dependent manner (r = 0.9166, r = 0.9572), thus confirming its anxiolytic effect. Network pharmacology results showed that 33 active components in BEO acted on 54 targets, mainly through modulation of neuroactive ligand-receptor interactions, G-protein coupled receptor signaling pathways, and RNA polymerase II transcription factor activity. PPI network analysis identified 48 key proteins, including estrogen receptor 1 (ESR1), androgen receptor (AR), and mitogen-activated protein kinase 8 (MAPK8). Molecular docking results showed that the main active components of BEO are borneol, β-caryophyllene, α-cadinol, limonene, and α- selinene, which act on the key targets CNR2, ADRA2B, and ADORA2A.Conclusion: Our results indicated that BEO has multi-component, multi-target, and multi-pathway characteristics, thus providing a theoretical basis for further research on the mechanism of action of BEO as a potential anxiolytic agent.